Avid Bioservices Inc (CDMO)

[entdoc]

this FTM message was deleted, and is herewith restored: "Lately I have been diverted by other things. "....." I am thinking that nanoviricides would be complementary to bavituximab. Many infected host cells will express PS on their surface when infected by a virus. Of course, bavi can target this PS and then macrophages can destroy the cell. However, bavi doesn't seem to be that great at attacking free floating virions in the blood. This is where the nanoviricides work. They don't work on infected cells, but on the virions. The combination may well eliminate the virus from the host. It would be great to try that out in a preclinical study. NanoViricides has a version for the Dengue virus in the works. Might be a good virus to try the combo on.